In addition, we also demonstrated that GCIP downregulated Id1 to render NSCLC cells more susceptibility to carboplatin and docetaxel, two commonly used anticancer drugs for NSCLC. The gene discussed is ID1; the disease is non-small cell lung carcinoma.